Thermo Fisher Scientific launched its new line of Thermo Scientific Staudinger Ligation Reagents for the in vitro and in vivo labeling of biomolecules.
In a statement, Thermo Fisher said that the Staudinger chemistry relies on azide-phosphine conjugation that works well in live-cell labeling and mass spectrometry applications. The reagents work especially well for the study of protein glycosylation, it added.
Caprotec Bioanalytics this week launched three new caproKits for the discovery, identification, and characterization of proteins belonging to the groups of metallo-proteases, histon-deacetylases, and GDP/GTP binding proteins.
The new kits are Marimastat caproKit, SAHA caproKit, and GDP caproKit, bringing the total number of caproKits to seven. The new kits target research into signal transduction, epigenetics, and proteases.
All the caproKits are based on the company's Capture Compound Mass Spectrometry technology for investigating small molecule-protein interactions. The CCMS platform is based on tri-functional molecules called capture compounds that allow for the isolation of proteins and protein classes directly from complex biological samples.